CLINICAL_TRIALS
trial_result
· 2024-07-15
Clinical Trial Update: Clinical Study of 18F-FAPI-RGD PET/CT in Rheumatoid Arthritis
Summary
A clinical study evaluating the 18F-FAPI-RGD PET/CT imaging agent for rheumatoid arthritis has completed its study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sichuan Provincial People's Hospital | Conditions: Rheumatoid Arthritis | Status: COMPLETED